Cited by 122MRI in cancer diagnosisAdvanced MRI Techniques and ApplicationsCharacterization and Applications of Magnetic Nanoparticles

Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T

Marchal, G, Van Hecke, P, Demaerel, P, Decrop, E, Kennis, C, Baert, AL, van der Schueren, E·1989·American Journal of Roentgenology

Abstract

The first clinical results of using superparamagnetic ferrite particles as a tissue-specific contrast agent for MR of the liver are reported at high fields (1.5 T). Fifteen patients with proved secondary liver malignancies were studied with plain and contrast-enhanced MR. Superparamagnetic iron oxide was administrated IV in a dose of 20 mumol/kg. Intermediate TR, 820/30, 60 (TR/TE), and long TR, 2200/22, 70, spin-echo sequences were used before and 1 hr after injection of contrast material. Before injection, the largest number of lesions (437) was detected with the T2-weighted sequence. Lesion-to-liver contrast, expressed as the difference between the tumor and liver signal-to-noise, improved after ferrite administration in both sequences from -1 to 20 and from 7 to 15 for the 820/30, 60 sequence and from 9 to 34 and 15 to 21 for the 2200/22, 70 sequence. Despite this significant improvement in terms of the number of lesions detected, contrast-enhanced images did not show significantly more metastases than the unenhanced T2-weighted images did (383, 421, 407, and 407 vs as many as 437, respectively). In this limited study at 1.5 T, the benefit of ferrite enhancement was only marginal when postcontrast images were compared with heavily T2-weighted precontrast scans.

Integrity signals

Registry

Crossref · 10.2214/ajr.152.4.771

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Due to high liver uptake, iron oxide nanoparticles have been employed relatively extensively for visualizing primary lesions in the liver, such as hepatocellular carcinoma and liver metastases.

    “Due to their high liver uptake, iron oxide nanoparticles have been employed relatively extensively for visualizing primary lesions in the liver, e.g. in case of hepatocellular carcinoma (HCC) (Figure 3 A, B) as well as liver metastases (Figure 3 C, D) [144, 145].”

Cited by

Sorted by citations

Authors
Marchal, G., Van Hecke, P., Demaerel, P., Decrop, E., Kennis, C., Baert, A., & van der Schueren, E.
Affiliations
  • KU Leuven (BE)
  • Department of Radiology, University Hospitals, K.U. Leuven, Belgium.
Venue
American Journal of Roentgenology
Published
1989-04-01
Volume
152
Issue
4
Pages
771-775
ISSN
  • 0002-9580 (ISSN-L)
  • 0361-803X
  • 1546-3141
OpenAlex
W1963756164
Cited by
122
References
0
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 1 · 2019: 3 · 2017: 1 · 2014: 2 · 2013: 4
FWCI
4.80
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Roentgenology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
  • Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
Keywords
liver metastasis, superparamagnetic iron oxide nanoparticles, MRI contrast agents, ferrite particles, contrast-enhanced MRI, T2-weighted imaging, lesion detection, 1.5T MRI
MeSH terms
Aged, Female, Ferric Compounds, Humans, Injections, Intravenous, Liver Neoplasms, Magnetic Resonance Imaging, Male, Middle Aged

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review